Skip to main content
. 2022 Jul;23(7):2497–2505. doi: 10.31557/APJCP.2022.23.7.2497

Table 1.

Clinical Pathological Findings in Patients with and without Biochemical Filure

No biochemical failure N=43 Biochemical Failure N= 36 p vañue
Mean age (SD) 66.7 ± 8.1 65.7 ± 8.8 p=0.78a
Median PSA ng/ml at diagnosis (IQR) 5.50 (4.54-6.57) 6.55 (5.10-6.42) p=0.07b
Stage
T1 9 (20%) 1 (2%) p=0.051
pT2 31 (72%) 31 (86%)
pT3 3 (8%) 4 (12%)
Gleason score
≤ 6 31 (72%) 31 (86%) p=0.46c
7 10 (23%) 5 (14%)
≥ 8 2 (5%) 0 (0%)
ECE
Yes 30 (69%) 19 (52%) p=0.19c
No 13 (31%) 17 (48%)
Median ALC (IIQR)
post surgery 2,400 (2,300-2,700) 1,900 (1,300-2,400) p< 0.0001b
last value 2,500 (2,200-2,750) 1,550 (900-1,900) p< 0.0001b
p=0..85b p=0.02b
Frequency LCP
Post surgery 38 (88%) 24 (66%) p=0.07c
>1,500 5 (12%) 7 (19%)
1,500-1,000 0 (0%) 5 (13%)
<1000
Last value
>1,500 38 (88%) 18 (50%) p=0.0005c
1,500-1,000 4 (9%) 8 (22%)
<1,000 1 (2%) 10 (28%)
p=0.57c p=0.27c

ECE, extra-capsulslar exten¡sion; ALC, absolute lymphocuyre count; LCP, lymphocytopenia; a, T.Test; b, Mann-Whitbey test; c, Fisheres exact test; last test, taken at biochemical failure or censure date